PT  - JOURNAL ARTICLE
AU  - Camargo, Araceli
AU  - Hossain, Elahi
AU  - Aliko, Sarah
AU  - Akinola-Odusola, Daniel
AU  - Artus, Josh
AU  - Kelman, Ilan
TI  - Using an Ecological and Biological Framing for an Anti-racist Covid-19 Approach
AID  - 10.1101/2021.01.24.21250397
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.24.21250397
4099  - http://medrxiv.org/content/early/2021/01/25/2021.01.24.21250397.short
4100  - http://medrxiv.org/content/early/2021/01/25/2021.01.24.21250397.full
AB  - In the United States and the United Kingdom COVID-19 has disproportionately affected Black, Indigenous and People of Colour (BIPOC) and Black, Asian and Minority Ethnic (BAME) people respectively. Multiple studies identify environmental factors such as overcrowded housing and poor workplace conditions as contributing factors for the disproportionate COVID-19 rates amongst BAME and BIPOC communities. This paper will show that to fully understand the phenomenon, both an ecological and biological approach is needed. An ecological approach highlights how a person’s habitat and the experiences within it mediate their susceptibility to disease. Moreover, to understand how this mediation works, this paper will use allostatic load as a biological pathway to link a person to their habitat and the poor health outcomes that contributed to COVID-19 susceptibility. In introducing this new approach, the paper will serve as an anti-racist framework for understanding how COVID-19 affected BAME and BIPOC communities. It is anti-racist by centring poor health outcomes on the habitats people are forced to live in due to structural racism rather than the physiology of a person’s race or ethnicity. This is important in order to avoid similar crises in the future and to improve the health of marginalised communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this manuscript has been obtained from the UK government open source database.